Novo Nordisk A/S (NVO) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Novo Nordisk A/S (NVO) short-term stock forecast for year 2025, month by month, and long-term NVO price prediction for years 2025 to 2050. Check NVO historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest NVO news and headlines.
1 Month Prediction
$247.74 [195.25%]
3 Month Prediction
$256.71 [205.93%]
6 Month Prediction
$271.72 [223.82%]
1 Year Prediction
$265.35 [216.23%]
3 Year Prediction
$319.67 [280.96%]
5 Year Prediction
$376.52 [348.72%]
About Novo Nordisk A/S
Novo Nordisk A/S is a global healthcare company that started with two small Danish companies who began producing insulin in 1923. Then, They merged in 1989 to create Novo Nordisk.
The company discovers, develops, and manufactures medicines for chronic diseases. They are known for developing treatments for diabetes, obesity, rare blood, and endocrine disorders.
Novo's main product is semaglutide. It is used for diabetes under the brand names Ozempic and Rybelsus. It is also used for obesity under the brand name Wegovy. Other drugs include Levemir, Tresiba, NovoLog, Novolin R, NovoSeven, and NovoEight
Novo Nordisk is involved in hemostasis management. They also work with growth disorders and hormone replacement therapy.
Novo Nordisk A/S (NVO) Historical Performance
IPO Date
Novo Nordisk A/S (NYSE:NVO) went public on 17 May, 1974.
Change
Since inception, NVO has increased by 78,926.95%. In the last 5 years, NVO has risen from $28.18 to $83.91, a massive 197.8% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $142.21 and a low of $28.18.
52 Week Range
$78.17
$148.15
The current price $83.91 is near the 52-week low, which means that the stock is underbought.
NVO Stock Price History
Based on NVO stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the NVO stock has risen from $27.21 - $32.95 to $83.91 - $84.45, which is up 247.8%. Currently, the stock follows upward trend.
Here, we have calculated stock range of NVO, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $27.21 - $32.95 | $30.33 | 25.31 | 1 Year Change |
| 2021 | $31.8 - $53.88 | $42.33 | 74.89 | 2 Year Change |
| 2022 | $48.04 - $66.08 | $54.23 | 124.06 | 3 Year Change |
| 2023 | $67.76 - $102.33 | $84.53 | 249.25 | 4 Year Change |
| 2024 | $86.02 - $142.21 | $121.53 | 402.12 | 5 Year Change |
| 2025 | $83.91 - $84.45 | $84.18 | 247.8 | 6 Year Change |
NVO Price Performance
6-Month Performance
NVO stock dropped by 29.53% in the last six months.
1-Year Performance
The stock has trended downwards by 33.93% in the past year.
3-Year Performance
In the last 3 years, the stock has soared by 57.07%.
5-Year Performance
In the last 5 years, the stock has gone up by 197.80%.
According to Novo Nordisk A/S's historical data, below graph gives us the exact picture of how the NVO stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 4 years and a decline in 1 year.
2020
21.62% ↑
2021
63.52% ↑
2022
22.66% ↑
2023
54.84% ↑
2024
15.94% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Novo Nordisk A/S (NVO) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $85.68 B (Q4)
Revenue for Q4 ending 31st December, 2024 increased 20.15% compared to Q3 ending 30th September, 2024.
Annual Revenue: $290.40 B (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
If compared to the last 4 years, the revenue has gone up from $140.80 billion to $290.40 billion, a 106.25% change.
Market Capitalization
Novo Nordisk A/S has a market capitalization of $388.55B, which places NVO in the mega-cap category.
Fundamental Analysis
EPS: $nan (Q4), $22.67 (1Y)
EPS decreased nan% since last quarter, and increased 21.42% since last year.
Net Income: $28.23 B (Q4), $100.99 B (1Y)
Net Income increased 3.40% since last quarter, and increased 20.68% since last year.
Free Cash Flow: $-4.26 B (Q4), $69.66 B (1Y)
Free Cash Flow decreased 113.58% since last quarter, and decreased 0.50% since last year.
Net Profit Margin: 32.95% (Q4), 34.78% (1Y)
Net Profit Margin decreased 13.94% since last quarter, and increased 20.68% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for NVO stock. These indicators help you understand Novo Nordisk A/S's financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for NVO stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $83.81 |
| SMA50 | $92.76 |
| SMA200 | $119.14 |
| RSI | 56.09 |
| Beta | 0.17 |
SMA20 < Current Price
This signals NVO stock is in short-term bullish momentum.
SMA50 > Current Price
This signals NVO stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals NVO stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for NVO stock is Neutral. Out of all indicators, 1 indicates bullish signals, 3 signals bearish trends and 5 gives neutral trends. The NVO stock forecast was last updated on 11 February, 2025.
Novo Nordisk A/S (NVO) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $253.88 by the end of 2025, and can reach around $294.15 to $287.22 in 2026. And, the long-term forecast suggests that the stock may further jump to $308.78 - $316.36 in 2028, and $391.79 - $404.29 by 2031. So, the NVO stock shows a strong upward trend in the next several years.
Short-term NVO Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $247.74 | 195.24% |
| 2025-04 | $248.68 | 196.37% |
| 2025-05 | $256.71 | 205.93% |
| 2025-06 | $266.61 | 217.73% |
| 2025-07 | $260.49 | 210.44% |
| 2025-08 | $271.72 | 223.82% |
| 2025-09 | $248.26 | 195.86% |
| 2025-10 | $251.98 | 200.3% |
| 2025-11 | $255.09 | 204.0% |
| 2025-12 | $253.88 | 202.56% |
In 2025, the NVO stock price is expected to fluctuate between $247.74 and $271.72. According to the monthly forecast, the stock could rise to $253.88 by December 2024. If compared to the NVO's current price, the stock could gain 202.56% by the end of this year.
Long-term NVO Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $294.15 | $261.08 | $287.22 | 242.3% |
| 2027 | $245.48 | $243.89 | $287.60 | 242.75% |
| 2028 | $308.78 | $307.25 | $316.36 | 277.02% |
| 2029 | $347.34 | $333.43 | $347.85 | 314.55% |
| 2030 | $385.24 | $398.38 | $436.67 | 420.4% |
| 2031 | $391.79 | $396.76 | $404.29 | 381.81% |
| 2032 | $458.79 | $402.85 | $443.88 | 429.0% |
| 2033 | $455.17 | $470.22 | $464.21 | 453.22% |
| 2034 | $492.78 | $424.42 | $503.10 | 499.57% |
| 2035 | $551.70 | $513.46 | $516.61 | 515.67% |
| 2036 | $620.86 | $587.55 | $583.60 | 595.51% |
| 2037 | $574.31 | $537.42 | $636.91 | 659.04% |
| 2038 | $575.31 | $617.61 | $624.80 | 644.61% |
| 2039 | $645.50 | $662.50 | $733.24 | 773.84% |
| 2040 | $608.63 | $644.58 | $643.13 | 666.45% |
| 2041 | $651.88 | $711.00 | $731.60 | 771.89% |
| 2042 | $721.17 | $707.56 | $831.41 | 890.84% |
| 2043 | $638.18 | $754.20 | $727.92 | 767.5% |
| 2044 | $820.71 | $687.09 | $809.85 | 865.14% |
| 2045 | $816.45 | $686.47 | $781.12 | 830.9% |
| 2046 | $796.46 | $796.95 | $683.59 | 714.67% |
| 2047 | $845.25 | $924.81 | $928.90 | 1007.02% |
| 2048 | $993.66 | $909.10 | $764.29 | 810.84% |
| 2049 | $973.20 | $1044.10 | $1034.21 | 1132.52% |
| 2050 | $868.20 | $849.03 | $863.63 | 929.23% |
| 2051 | $1012.67 | $881.72 | $860.10 | 925.03% |
Novo Nordisk A/S (NVO) Stock Price Prediction & Forecast 2025
At the start of 2025, the NVO stock was at $84.45. Today, it is trading at $83.91, which is -0.64% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $253.88 by December 2025 with a 202.56% change.
Novo Nordisk A/S (NVO) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the NVO stock. During this period, the NVO's price is forecasted to shift from $294.15 to $436.67, which is 48.45% gain.
In 2026, the stock would possibly open at $294.15, descends to $261.08 by mid-year, and wraps up at $287.22, reflecting a 242.30% increase from today's price. Further moving to 2030, the stock can kick off the year at $385.24, drop to $398.38 by mid-year, and finish at $436.67, which is 420.40% change from current price.
Novo Nordisk A/S (NVO) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $391.79 to $643.13, which is up 381.81%
In 2031, we can expect NVO to fluctuate between $391.79 and $404.29, a shift indicating a 381.81% gain by year-end compared to current price. And Until 2040, NVO can likely vary from $608.63 to $643.13. By the end of 2040, the stock could record a 666.46% rise from today's stock price.
Novo Nordisk A/S (NVO) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the NVO stock can see an an upturn from $651.88 to $863.63 in this period. In 2041, the stock can experience a high of $711.00 by mid-year, closing the year at $731.60. This results in a 747.34% increase from today.
Moving towards the end of 2050, NVO is projected to open the year at $868.20. The stock may dip to $849.03 during mid-year and finish the year at $863.63. Compared to the stock's current price, this translates to an overall gain of 929.23% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
NVO Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | - | $210.75 | 0.82% ▲ | $81.29 ▲ |
| LLY | Eli Lilly and Company | - | $844.27 | 4.09% ▲ | $112.92 ▲ |
| JNJ | Johnson & Johnson | - | $153.12 | 0.64% ▲ | $92.65 ▲ |
| PFE | Pfizer Inc. | - | $25.74 | -1.34% ▼ | $105.29 ▲ |
Last updated Feb 11 at 3:26 PM
NVO : Buy, Sell Or Hold?
Analyst Ratings
Based on 8 analysts, 1 rated as a strong buy, 3 recommended a buy, 3 suggested a hold, 1 advised a sell, and 0 indicated a strong sell.Three months ago, out of 8 analysts, 1 analysts gave a strong buy rating, 4 a buy rating, 2 a hold rating, 1 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for NVO stock is Buy.
Expert Analysis
According to NVO short-term and long-term forecast, Novo Nordisk A/S shares are projected to go up by 929.23%, and reach a value of $863.63 per share by 2050.
As per technical analysis, indicators show a Neutral sentiment, while Fear & Greed Index stands at 28.571428571428573, which signals Fear. Also, NVO has recorded 8/30 green days, which reflects a 40.0% positivity rate with a price volatility of 0.03%.
Plus, Price-to-Earnings (P/E) ratio of 26.808308 suggests that NVO stock is overvalued. So, Based on NVO prediction and analysis, it may be the best time to hold NVO stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "NVO” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.